Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2022 June;64(2) > Panminerva Medica 2022 June;64(2):228-34



Opzioni di pubblicazione
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca


Publication history
Per citare questo articolo



Panminerva Medica 2022 June;64(2):228-34

DOI: 10.23736/S0031-0808.21.04144-6


lingua: Inglese

IC4: a new combined predictive index of mortality in idiopathic pulmonary fibrosis

Angelo ZINELLU 1 , Claudia COLLU 2, Elisabetta ZINELLU 3, Kaïs AHMAD 4, Mouhamad NASSER 4, Julie TRACLET 4, Elisabetta SOTGIU 1, Sabrina MELLINO 1, Arduino A. MANGONI 5, Ciriaco CARRU 1, Pietro PIRINA 2, 3, Vincent COTTIN 4, 6, Alessandro G. FOIS 2, 3

1 Department of Biomedical Sciences, University of Sassari, Sassari, Italy; 2 Department of Medical, Surgical, and Experimental Sciences, University of Sassari, Sassari Italy; 3 Unit of Respiratory Diseases, Sassari University Hospital, Sassari, Italy; 4 Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Lyon, France; 5 Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Center, Adelaide, Australia; 6 UMR754, Claude Bernard University Lyon 1, Lyon, France

BACKGROUND: While a number of individual patient characteristics are associated with survival in idiopathic pulmonary fibrosis (IPF), their incorporation into combined indexes, such as the GAP index, has been shown to increase the predictive capacity. It is unknown whether the predictive capacity of GAP-derived indexes that also include anthropometric and exercise parameters is superior to the original instrument.
METHODS: We tested the four-year survival predictive capacity of a modified, adimensional and multiplicative GAP index (IC4) that included percent forced vital capacity (FVC%), diffusing capacity of the lung for carbon monoxide (DLCO%), Body Mass Index (BMI), and six-minute walk distance (6MWD) in 90 IPF patients recruited from two centers in France and Italy.
RESULTS: In ROC comparisons, the AUC of the IC4 (0.859, 95% CI 0.770-0.924 P<0.0001) was significantly higher than the AUCs of the individual components, their two-three component combinations, and the original GAP index, with 77% sensitivity and 89% specificity. Mean survival was 14.0±11.7, 23.2±12.7, 34.9±14.8, and 40.8±12.9 months, and survival rate was 0%, 14%, 39% and 73%, in IC4 quartile 1, 2, 3, and 4, respectively.
CONCLUSIONS: The IC4, a combined non-dimensional index incorporating FVC%, DLCO%, BMI and 6MWD, provides superior capacity to predict mortality, when compared to its individual components, their other combinations, and the GAP index, in patients with IPF.

KEY WORDS: Pulmonary fibrosis; Mortality; Prognosis

inizio pagina